Review
Chemoprevention of esophageal squamous cell carcinoma

https://doi.org/10.1016/j.taap.2007.01.030Get rights and content

Abstract

Esophageal squamous cell carcinoma (SCC) is responsible for approximately one-sixth of all cancer-related mortality worldwide. This malignancy has a multifactorial etiology involving several environmental, dietary and genetic factors. Since esophageal cancer has often metastasized at the time of diagnosis, current treatment modalities offer poor survival and cure rates. Chemoprevention offers a viable alternative that could well be effective against the disease. Clinical investigations have shown that primary chemoprevention of this disease is feasible if potent inhibitory agents are identified. The Fischer 344 (F-344) rat model of esophageal SCC has been used extensively to investigate the biology of the disease, and to identify chemopreventive agents that could be useful in human trials. Multiple compounds that inhibit tumor initiation by esophageal carcinogens have been identified using this model. These include several isothiocyanates, diallyl sulfide and polyphenolic compounds. These compounds influence the metabolic activation of esophageal carcinogens resulting in reduced genetic (DNA) damage. Recently, a few agents have been shown to inhibit the progression of preneoplastic lesions in the rat esophagus into tumors. These agents include inhibitors of inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), vascular endothelial growth factor (VEGF) and c-Jun [a component of activator protein-1 (AP-1)]. Using a food-based approach to cancer prevention, we have shown that freeze-dried berry preparations inhibit both the initiation and promotion/progression stages of esophageal SCC in F-344 rats. These observations have led to a clinical trial in China to evaluate the ability of freeze-dried strawberries to influence the progression of esophageal dysplasia to SCC.

Introduction

Esophageal cancer in humans occurs worldwide with a variable geographic distribution and ranks sixth as a cause of cancer mortality (Parkin et al., 2001). There are two main types of esophageal cancer with distinct etiological and pathological characteristics, squamous cell carcinoma (SCC) and adenocarcina. Esophageal SCC is the predominant type of esophageal malignancy worldwide, although adenocarcinomas are more prevalent in the USA (Souza, 2002). Epithelial dysplasia, characterized by an accumulation of atypical cells with nuclear hyperchromasia, abnormally clumped chromatin and loss of polarity, is the principal precursor lesion of esophageal SCC (Krasna and Wolfer, 1996). Esophageal SCC develops through a progressive sequence from mild to severe dysplasia, carcinoma in situ and, finally, invasive carcinoma (Anani et al., 1991, Kuwano et al., 1993, Shu et al., 1981). The tumors present as fungating, ulcerating or infiltrating lesions in the esophageal epithelium. Most esophageal cancer patients present with advanced metastatic disease at the time of diagnosis (Layke and Lopez, 2006). This results in a poor prognosis; only 1 in 5 esophageal cancer patients survives more than 3 years after initial diagnosis (Polednak, 2003, Younes et al., 2002).

Section snippets

Epidemiology of esophageal SCC

The incidence of esophageal SCC shows marked variation in its geographic distribution and occurs at very high frequencies in certain parts of China, Iran, South Africa, Uruguay, France, Italy and Puerto Rico (Krasna and Wolfer, 1996, Rose, 1973, Schottenfeld, 1984, Sons, 1987, Stoner and Gupta, 2001, Yang, 1980). One-half of all esophageal SCC in the world occurs in China. Areas located in the southern parts of the Taihang mountains on the borders of Henan, Shansi and Hopei provinces have among

Etiology of esophageal SCC

There are several factors involved in the etiology of esophageal SCC (Stoner and Gupta, 2001). The excessive use of tobacco is a principal risk factor for this disease (Layke and Lopez, 2006). Several tobacco carcinogens, including certain nitrosamines, polycyclic aromatic hydrocarbons and aromatic amines, and toxins, including aldehydes and phenols, may be causally related to esophageal cancer (Hecht and Stoner, 1996, Tuyns, 1982, Wynder and Bross, 1961). Alcohol consumption has been shown to

Prevention of esophageal SCC

One approach to the prevention of esophageal SCC is through changes in lifestyle, especially the avoidance of alcohol and tobacco use. Additional benefits may be realized by the elimination of high salt foods that may be contaminated with microbial toxins, nitrosamines and their precursors. The increased consumption of vegetables and fruit throughout the world, and especially in the high-risk areas for esophageal SCC, might also be expected to reduce the incidence and mortality from the

Rat esophageal tumor model

Nitrosamine-induced tumorigenesis in the Fischer-344 rat has proven to be a valuable animal model for studies of the molecular biology and chemoprevention of esophageal SCC (Beer and Stoner, 1998, Hecht and Stoner, 1996, Stoner and Gupta, 2001). Several nitrosamines, including the food contaminant, N-nitrosomethylbenzylamine (NMBA), and the tobacco-specific nitrosamine, N-nitrosonornicotine (NNN), induce tumorigenesis in the rat esophagus (Fig. 1) (Stoner and Gupta, 2001). NMBA is by far the

Chemoprevention studies in rat esophagus

Mechanistically, chemopreventive agents have been classified as either “blocking” agents or “suppressing” agents (Wattenberg, 1985). Blocking agents act at the initiation stage of carcinogenesis through their influence on the metabolism of carcinogens leading, ultimately, to reduced damage to cellular DNA. Suppressing agents act on the promotion/progression stages of carcinogenesis by influencing cell proliferation rates, apoptosis, differentiation, angiogenesis, tissue invasion, etc. Several

Chemoprevention of human esophageal squamous cell carcinoma

An important component in chemoprevention of human esophageal SCC is that of blocking the progression of premalignant lesions, such as epithelial dysplasia, to malignant SCC (Wang et al., 2005). With the availability of endoscopic and cytological screening techniques, the identification and follow-up of esophageal dysplasia among high-risk populations have become possible. The use of “balloon cytology” coupled with endoscopy in China has proven useful in identifying individuals with

Conclusions

The 5-year survival rate for esophageal SCC has not improved substantially in the past several decades in spite of advances in surgical techniques, radiotherapy and chemotherapy. Prevention is clearly an important approach to reduce the incidence and mortality from this disease. Lifestyle changes, especially the avoidance of tobacco and alcohol use, and the elimination of high salt and moldy foods, would reduce the incidence and mortality from the disease. In addition, the increased consumption

References (123)

  • J.Y. An et al.

    Loss of heterozygosity in multistage carcinogenesis of esophageal carcinoma at high-incidence area in Henan Province, China

    World J. Gastroenterol.

    (2005)
  • P.A. Anani et al.

    An extensive morphological and comparative study of clinically early and obvious squamous cell carcinoma of the esophagus

    Pathol. Res. Pract.

    (1991)
  • T. Ando et al.

    Decreased expression of NDRG1 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma

    Dis. Esophagus

    (2006)
  • K. Anupam et al.

    Loss of disabled-2 expression is an early event in esophageal squamous tumorigenesis

    World J. Gastroenterol.

    (2006)
  • M. Asamoto et al.

    Transgenic rats carrying human c-Ha-ras proto-oncogene are highly susceptible to N-nitrosomethylbenzylamine induction of esophageal tumorigenesis

    Jpn. J. Cancer Res.

    (2002)
  • D.H. Barch et al.

    Dietary ellagic acid reduces the esophageal microsomal metabolism of methylbenzylnitrosamine

    Cancer Lett.

    (1989)
  • D.G. Beer et al.

    Clinical models of chemoprevention for the esophagus

    Hematol. Oncol. Clin. North Am.

    (1998)
  • J.F. Brady et al.

    Effect of diallyl sulfide on rat liver microsomal nitrosamine metabolism and other monooxygenase activities

    Cancer Res.

    (1988)
  • D.G. Carlson et al.

    Glucosinolates in crucifer vegetables: turnips and rutabagas

    J. Agric. Food Chem.

    (1981)
  • P.S. Carlton et al.

    Inhibition of N-nitrosomethylbenzylamine-induced tumorigenesis in the rat esophagus by dietary freeze-dried strawberries

    Carcinogenesis

    (2001)
  • P.S. Carlton et al.

    Piroxicam is an ineffective inhibitor of N-nitrosomethylbenzylamine-induced tumorigenesis in the rat esophagus

    Cancer Res.

    (2002)
  • M.S. Chang et al.

    Differential protein expression between esophageal squamous cell carcinoma and dysplasia, and prognostic significance of protein markers

    Pathol. Res. Pract.

    (2005)
  • T. Chen et al.

    Inducible nitric oxide synthase expression in N-nitrosomethylbenzylamine (NMBA)-induced rat esophageal tumorigenesis

    Mol. Carcinog.

    (2004)
  • T. Chen et al.

    Chemopreventive effects of a selective nitric oxide synthase inhibitor on carcinogen-induced rat esophageal tumorigenesis

    Cancer Res.

    (2004)
  • T. Chen et al.

    Chemopreventive properties of black raspberries in N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis: down-regulation of cyclooxygenase-2, inducible nitric oxide synthase, and c-Jun

    Cancer Res.

    (2006)
  • T. Chen et al.

    Black raspberries inhibit N-nitrosomethylbenzylamine (NMBA)-induced angiogenesis in rat esophagus parallel to the suppression of COX-2 and iNOS

    Carcinogenesis

    (2006)
  • D.A. Corley et al.

    Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis

    Gastroenterology

    (2003)
  • E.M. Daniel et al.

    The effects of ellagic acid and 13-cis-retinoic-acid on N-nitrosomethylbenzylamine-induced esophageal tumorigenesis in rats

    Cancer Lett.

    (1991)
  • E.M. Daniel et al.

    Extraction, stability and quantitation of ellagic acid in various fruits and nuts

    J. Food Compos. Anal.

    (1989)
  • J.G. de Boer et al.

    Chemoprotection against N-nitrosomethylbenzylamine-induced mutation in the rat esophagus

    Nutr. Cancer

    (2004)
  • H.J. Freeman

    Risk of gastrointestinal malignancies and mechanisms of cancer development with obesity and its treatment

    Best Pract. Res. Clin. Gastroenterol.

    (2004)
  • Y. Fujiwara et al.

    Suppressive effect of CPT-11 on rat esophageal tumorigenesis induced by N-nitrosomethylbenzylamine

    Oncol. Rep.

    (2004)
  • H. Gao et al.

    p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China

    Cancer Res.

    (1994)
  • T. Gotoh et al.

    Chemoprevention of N-methyl-N-nitrosourea induced rat mammary carcinogenesis by soy foods or biochanin A

    Jpn. J. Cancer Res.

    (1998)
  • Y.J. Guo et al.

    Amplification of int-2 gene in primary esophageal carcinoma and fetal esophageal carcinoma induced by N-methyl-N-benzylnitrosamine

    Chin. J. Oncol.

    (1993)
  • A. Gupta et al.

    Effects of dietary N-(4-hydroxyphenyl)retinamide on N-nitrosomethylbenzylamine metabolism and esophageal tumorigenesis in the Fischer 344 rat

    J. Natl. Cancer Inst.

    (2001)
  • A.B. Hanley et al.

    Improved isolation of glucobrassicin and other glucosinolates

    J. Sci. Food Agric.

    (1983)
  • S.S. Hecht et al.

    Lung and esophageal carcinogenesis

  • T. Hiyama et al.

    Overexpression of human telomerase RNA is an early event in esophageal carcinogenesis

    Virchows Arch.

    (1999)
  • M. Hollstein et al.

    Amplification of EGF receptor gene but no evidence of ras mutations in primary human esophageal cancers

    Cancer Res.

    (1988)
  • M. Hollstein et al.

    Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutations

    Cancer Res.

    (1991)
  • G. Hu et al.

    Lack of effects of selenium on N-nitrosomethylbenzylamine-induced tumorigenesis, DNA methylation and oncogene expression in rats and mice

    Nutr. Cancer

    (1992)
  • T.S. Hudson et al.

    Investigation of the enhancement of NMBA-induced esophageal tumorigenesis by 6-phenylhexyl isothiocyanate

    Cancer Lett.

    (2001)
  • J.S. Hughes et al.

    Dry beans inhibit azoxymethane-induced colon carcinogenesis in F344 rats

    J. Nutr.

    (1997)
  • A. Ishikawa et al.

    Smoking, alcohol drinking, green tea consumption and the risk of esophageal cancer in Japanese men

    J. Epidemiol.

    (2006)
  • W. Jiang et al.

    Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer

    Proc. Natl. Acad. Sci. U.S.A.

    (1993)
  • L. Khare et al.

    Altered localization of E-cadherin and alpha-catenin in rat esophageal tumors

    Int. J. Oncol.

    (1999)
  • Y. Kimura et al.

    Cytoplasmic β-catenin in esophageal cancers

    Int. J. Cancer Pred. Oncol.

    (1999)
  • M.J. Krasna et al.

    Esophageal carcinoma: diagnosis, evaluation and staging

  • L.A. Kresty et al.

    Chemoprevention of esophageal tumorigenesis by dietary administration of lyophilized black raspberries

    Cancer Res.

    (2001)
  • T. Kuno et al.

    Preventive effect of fermented brown rice and rice bran on N-nitrosomethylbenzylamine-induced esophageal tumorigenesis in rats

    Int. J. Oncol.

    (2004)
  • T. Kuroki et al.

    Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma

    Cancer Res.

    (2003)
  • H. Kuwano et al.

    Squamous epithelial dysplasia associated with squamous cell carcinoma of the esophagus

    Cancer Lett.

    (1993)
  • A.K.Y. Lam

    Molecular biology of esophageal squamous cell carcinoma

    Crit. Rev. Oncol. Hematol.

    (2000)
  • J.C. Layke et al.

    Esophageal cancer: a review and update

    Am. Fam. Phys.

    (2006)
  • M.N. Li et al.

    Etiology of carcinoma of the esophagus

  • M.H. Li et al.

    Occurrence of nitroso compounds in fungi-contaminated foods: a review

    Nutr. Cancer

    (1986)
  • Z.G. Li et al.

    Suppression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by JTE-522, a selective COX-2 inhibitor

    Carcinogenesis

    (2001)
  • Z.G. Li et al.

    Suppression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by resveratrol

    Carcinogenesis

    (2002)
  • Z.G. Li et al.

    Inhibitory effects of epigallocatechin-3-gallate on N-nitrosomethylbenzylamine-induced esophageal tumorigenesis in F344 rats

    Int. J. Oncol.

    (2002)
  • Cited by (76)

    • N-nitrosamines-mediated downregulation of LncRNA-UCA1 induces carcinogenesis of esophageal squamous by regulating the alternative splicing of FGFR2

      2023, Science of the Total Environment
      Citation Excerpt :

      Surprisingly, there were higher measured concentrations of NDEA and NMEA in human urine in high incidence ESCC areas compared to lower incidence ESCC areas (Zhao et al., 2019). It is generally accepted that the carcinogenic effects of NAs mainly associated with their active electrophilic intermediates, leading to DNA alkylation damage (Stoner et al., 2007). So far, however, the results have not been conclusive (Menya et al., 2019; Sheikh et al., 2019; Totsuka et al., 2019; Zhao et al., 2019).

    • Metabolomic transition trajectory and potential mechanisms of N-nitrosomethylbenzylamine induced esophageal squamous cell carcinoma in rats

      2022, Ecotoxicology and Environmental Safety
      Citation Excerpt :

      Because of the difficulty in obtaining continuous tumorigenic specimens from human, addressing this issue would be highly dependent on animal models. Fortunately, it has been shown that NMBA can specifically induce tumorigenesis in the esophagus of rats in the same sequence as the progression of human ESCC (Stoner et al., 2007). Numerous abnormalities have been identified in the esophageal cancerization of rats induced by NMBA, such as the p53, cyclooxygenase 2 (COX2), vascular endothelial growth factor (VEGF) (Stoner et al., 2007), nuclear factor kappa B (NF-κB) (Cui et al., 2019), AMP-activated protein kinase (AMPK)/mammalian target of the rapamycin (mTOR) signaling pathway (Fan et al., 2019), and so on.

    • Metabolomics-based molecular signatures reveal the toxic effect of co-exposure to nitrosamines in drinking water

      2022, Environmental Research
      Citation Excerpt :

      Epidemiological findings have reported that nitrosamines exposure can increase the risks of some gastrointestinal diseases (Fritschi et al., 2015; Gu et al., 2016; Zeng et al., 2015; Zhao et al., 2020). Toxicological assays have demonstrated that nitrosamines can induce tumorigenesis via multiple mechanisms, such as generating adducts, interfering DNA repair, altering epigenetic or genomic stability, activating receptor-mediated signaling, causing immunosuppression, and influencing cell proliferation (Fishbein et al., 2020; Gu et al., 2016; Stoner et al., 2007; Zeng et al., 2015). Traditional approaches, monitoring a small number of pre-designed targets, are often inadequate for fully assessing the hazardous effects of nitrosamines.

    • Urinary exposure of N-nitrosamines and associated risk of esophageal cancer in a high incidence area in China

      2020, Science of the Total Environment
      Citation Excerpt :

      Among the suspected factors in the environment, N-nitrosamine compounds are a class of the most probable carcinogens concerned with EC. Carcinogenesis of nitrosamines mainly arises from their active electrophilic intermediates which lead to DNA alkylation damage (Stoner et al. 2007). Toxicological data have proven that nitrosamines can induce tumors in the esophagus of experimental animals along with a string of molecular events (Ushida et al. 2000; Stoner et al. 2007; Li et al. 2002).

    View all citing articles on Scopus
    View full text